CORE - Temple University — Philadelphia, Pennsylvania

CORE - Temple University is a clinical research site located in Philadelphia, Pennsylvania, United States 19140.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

CORE - Temple University has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CORE - Temple University?

CORE - Temple University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CORE - Temple University conducted?

CORE - Temple University has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is CORE - Temple University accredited by Crixeo Health?

CORE - Temple University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CORE - Temple University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.